Publication | Closed Access

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

ContraceptionHormonal ContraceptiveOral ContraceptiveMedicineReproductive HealthGynecologyNew ProgestogenMulticenter StudyEndocrinologyPharmacologyWomen's HealthReproductive Endocrinology